FOLH1 and neoplasm: The tumor half-life of FAP-2286 is much longer than that of FAPI-02 or FAPI-04 but less than that of 177Lu-PSMA, 177Lu-DOTATOC, or 177Lu-DOTATATE (14,21,25).